PAPARO, SABRINA ROSARIA
 Distribuzione geografica
Continente #
EU - Europa 437
NA - Nord America 388
AS - Asia 70
AF - Africa 56
Totale 951
Nazione #
US - Stati Uniti d'America 388
IT - Italia 231
SE - Svezia 134
SG - Singapore 53
CI - Costa d'Avorio 30
DE - Germania 21
BG - Bulgaria 16
SN - Senegal 15
NG - Nigeria 11
IE - Irlanda 8
AT - Austria 7
CN - Cina 5
FR - Francia 5
IN - India 5
PL - Polonia 4
CH - Svizzera 3
GB - Regno Unito 3
NL - Olanda 3
HK - Hong Kong 2
IR - Iran 2
VN - Vietnam 2
FI - Finlandia 1
JP - Giappone 1
UA - Ucraina 1
Totale 951
Città #
Pisa 80
Chandler 72
Serra 33
Abidjan 30
Ashburn 28
Fairfield 27
Boardman 24
New York 22
Florence 20
Milan 18
Cambridge 16
Sofia 16
Dakar 15
Singapore 14
Wilmington 13
Woodbridge 12
Bremen 11
Lagos 11
Lawrence 11
Princeton 11
Carrara 10
Frankfurt am Main 10
Livorno 10
Rome 10
Los Angeles 9
Dublin 8
Houston 8
Medford 7
Seattle 7
Vienna 7
San Diego 6
Ogden 5
Ann Arbor 4
Hyderabad 4
Norwalk 4
Warsaw 4
Washington 4
Amsterdam 3
Bern 3
Beijing 2
Cascina 2
Castano Primo 2
Cavriglia 2
Gabbro 2
Hong Kong 2
London 2
Lucca 2
Naples 2
Palermo 2
Sant'Anastasia 2
Dong Ket 1
Kilburn 1
Kish 1
Kundan 1
Lappeenranta 1
Mugnano di Napoli 1
Pessac 1
Phoenix 1
Pietrasanta 1
Pomezia 1
Redmond 1
Redwood City 1
San Jose 1
Tehran 1
Torino 1
Turin 1
Totale 645
Nome #
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin 97
THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors 91
Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer 84
Nutraceuticals in thyroidology: A review of in vitro, and in vivo animal studies 73
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 70
Molecular targets of tyrosine kinase inhibitors in thyroid cancer 65
Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism 62
Advances in pharmacotherapy for advanced thyroid cancer of follicular origin (PTC, FTC). New approved drugs and future therapies 61
Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases 58
L-T4 Therapy in Enteric Malabsorptive Disorders 48
Precision Medicine in Graves’ Disease and Ophthalmopathy 47
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 43
Chemokines in thyroid autoimmunity 36
Teprotumumab for the treatment of thyroid eye disease 34
Molecular features of aggressive thyroid cancer 30
Graves' disease induced by IFN-β1a therapy: A case report, review of literature and new insights into the pathogenesis 30
Antineoplastic Activity of Pazopanib in Anaplastic Thyroid Cancer in Primary Culture 27
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series 26
Thyroid Metastasis from Primary Breast Cancer 23
Graves' Disease Following SARS-CoV-2 Vaccination: A Systematic Review 15
Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature Review 12
Totale 1.032
Categoria #
all - tutte 4.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.339


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202171 0 0 21 0 11 2 7 5 9 5 9 2
2021/2022239 0 0 8 14 24 37 21 8 34 40 22 31
2022/2023311 42 39 23 13 29 24 17 20 70 3 25 6
2023/2024294 18 21 59 41 28 39 21 5 3 10 18 31
2024/2025117 64 22 31 0 0 0 0 0 0 0 0 0
Totale 1.032